Steve Greene, MD, discusses the results of a TRANSFORM-HF analysis comparing the effects of furosemide and torsemide on quality of life outcomes in patients with heart failure.
“The Heart in Diabetes (HiD) conference, entering its seventh year, is a renowned medical meeting that brings together global clinical leaders in diabetes, obesity and cardiorenal metabolic diseases together with practicing clinicians to improve the care of patients at a high risk of these comorbidities. This is a unique and exciting multidisciplinary program: Where the Heart, Kidney, and